Express Scripts (NASDAQ:ESRX) insider Christine Houston sold 19,889 shares of the company’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total transaction of $1,525,287.41. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of ESRX stock traded up $1.89 during trading hours on Thursday, reaching $71.61. The stock had a trading volume of 3,750,193 shares, compared to its average volume of 5,232,093. The company has a quick ratio of 0.55, a current ratio of 0.67 and a debt-to-equity ratio of 0.83. Express Scripts has a twelve month low of $55.80 and a twelve month high of $85.07. The stock has a market cap of $39,206.10, a PE ratio of 10.09, a price-to-earnings-growth ratio of 0.86 and a beta of 0.99.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, February 27th. The company reported $2.16 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.09 by $0.07. Express Scripts had a net margin of 4.51% and a return on equity of 25.19%. The business had revenue of $25.38 billion for the quarter, compared to analysts’ expectations of $25.07 billion. During the same quarter last year, the company earned $1.88 EPS. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. equities analysts forecast that Express Scripts will post 9.33 EPS for the current fiscal year.
Express Scripts announced that its board has authorized a share buyback program on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.
A number of research analysts have commented on the stock. ValuEngine downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. BidaskClub downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Wednesday, March 14th. Zacks Investment Research downgraded shares of Express Scripts from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 13th. Sanford C. Bernstein upgraded shares of Express Scripts from an “underperform” rating to a “market perform” rating in a research note on Monday, March 12th. Finally, Wells Fargo upgraded shares of Express Scripts from an “underperform” rating to a “market perform” rating in a research note on Friday, March 9th. Three investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and five have assigned a buy rating to the stock. Express Scripts currently has a consensus rating of “Hold” and an average target price of $81.97.
Several hedge funds have recently added to or reduced their stakes in ESRX. SeaCrest Wealth Management LLC acquired a new stake in shares of Express Scripts in the 4th quarter worth about $105,000. Bank of Nova Scotia Trust Co. acquired a new stake in shares of Express Scripts in the 3rd quarter worth about $120,000. Aevitas Wealth Management Inc. acquired a new stake in shares of Express Scripts in the 4th quarter worth about $128,000. Financial Gravity Companies Inc. acquired a new stake in shares of Express Scripts in the 4th quarter worth about $142,000. Finally, Monroe Bank & Trust MI increased its holdings in shares of Express Scripts by 74.8% in the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after acquiring an additional 970 shares during the period. 89.39% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Express Scripts (ESRX) Insider Christine Houston Sells 19,889 Shares” was published by Macon Daily and is the property of of Macon Daily. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://macondaily.com/2018/04/12/christine-houston-sells-19889-shares-of-express-scripts-holding-esrx-stock-updated-updated-updated.html.
Express Scripts Company Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.